The buildings are about 98% leased. Novartis leases but does notoccupy the 60,000-sf lab building at 930 Clopper Rd., subleasing itto another tenant. Fusion UV Systems, Genetic Therapy and Scientechare tenants in the complex.
The real estate investment trust Boston Properties sold thebuildings because they didn't fit the company's portfolio. Cassidy& Pinkard represented the seller. MGP represented itself.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
